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Investigationsofthe patterns ofoccurrence ofmultiple primary cancers ofthesameorgan or of
differentorgans provideimportant dataconcerning thecarcinogenic potential ofvarioustherapies
used in the treatment ofcancer. Associations between cancers arising in differentorgans may also
suggest hypotheses concerning shared risk factors that are strongly related to the incidence of
both types of tumors. Studies of multiple primaries of a single organ permit exploration of a
numberofquestions ofetiologic interest. First, a strong same-siteassociation over and abovewhat
would be expected on the basis ofknown risk factors suggests that the unexplained proportion of
cancer incidence represents relatively stable characteristics of individuals rather than sporadic
events. Second, detailed comparisons of risk factors for first versus second primaries of a
particular site may help to identify etiologically distinct subtypes of the disease. Third, even if
distinct subtypesdo notexist, thestudyofrisk factors for a second primaryamong thosewho have
had a first primary ofthe same site may enhance the detection ofthe etiologic role ofa particular
exposure. Such detection isenhanced when the effects ofthe exposure are modified by some other
factor that is itself a strong risk factor but that is not measured. Finally, studies of multiple
primaries of a single site are of particular benefit to clinicians who must decide on appropriate
levels ofsurveillance and preventive intervention.
Patterns of multiple primary cancer have intrigued researchers for decades [1-22].
In light of this continuing interest and the ready availability of data on multiple
primaries from cancer registries around the world, it seems worthwhile to examine the
nature ofthe inferences that can be drawn from empirical studies ofmultiple primary
cancers. In this paper I will first consider the interpretation of associations involving
two different organs and will then discuss multiple primaries of a single organ, with
particular emphasis on the risk of developing contralateral breast cancer among
women with a first primary breast cancer.
MULTIPLE PRIMARY CANCERS IN DIFFERENT ORGANS
Even in the absence of any systematic bias due to the effects of misclassification or
other methodologic problems, a number ofpossible interpretations must be considered
for an observed elevation in the risk of one type of primary cancer subsequent to the
diagnosis of some other primary cancer. It may be that the initial cancer has some
lasting effect on patients that alters their susceptibility to a new primary. Available
evidence indicates that any overall increase in susceptibility seems to be modest, if in
fact it exists at all. Rates for subsequent cancer of any site among those with a first
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primary are only slightly elevated relative to rates in the general population [16], and
part ofthis apparent excess may be an artifact ofan increased level ofsurveillance for
people who have had a first primary cancer.
The effects of treatment are a second possible explanation for an observed elevation
in the riskofa particular cancer among those with a first primaryofanothersite. Thus,
for example, observed associations between cervical cancer and subsequent risk of
cancer of the rectum [23] may reflect radiation-induced cancer as a result of the
radiotherapy that is often given to patients with cervical cancer. Widespread use of
chemotherapeutic agents may also account for associations between specific types of
primary cancer. In general, overall examination of associations between types of
cancer is not the most useful method for assessing possible carcinogenic effects of
cancer therapy. More informative is a comparison ofrisks for second primaries among
those receiving various treatment modalities for first primary cancer. Instead of
comparing the risk for all persons with a given first primary to the risk in the general
population, one makes comparisons within the patient group. This approach has the
advantage of isolating the effects of particular modalities, whereas grouping all
patients with a given primary would obscure an effect for a treatment that is given to
only a subgroup of patients with the first primary cancer under investigation. This
approach also has the advantage of eliminating the potential for confounding due to
differences between cancer patients and the general population in terms oftheir levels
on risk factors related to the incidence of the subsequent primary cancer under study.
Shared Risk Factors
Ofpotential etiologic interest is the possibility that an association between two types
of primary cancer reflects a causal relationship between a risk factor and each of the
two cancers. If two cancers are known to share a particular risk factor, then
demonstration of an association between the two cancers in a study of multiple
primaries would serve as confirmation of the etiologic role ofthe risk factor. Thus, for
example, because of the effects of smoking, one would expect to observe an elevated
risk of bladder cancer among patients with a first primary cancer of the lung. The
empirical demonstration of such an association [24] confirms the etiologic role of
smoking in both types of cancer. Similarly, an observed elevation in the risk of
subsequent endometrial cancer among women with a first primary cancer ofthe breast
[25,26] reflects at least in part the reproductive factors that have been shown in
extensive analytic studies to be related to the incidence ofboth cancers [27]. Ofgreater
interest to epidemiologists would be associations between cancers that had not
previously been known to share any risk factor. In those instances, the epidemiologist
may be confronted with an important new lead concerning the etiology ofboth types of
cancer.
When attempting to assess the reasonableness of a shared risk factor as an
explanation for an observed association between two types of cancer, the judgment
made is usually a qualitative one. That is, if one or more risk factors are known to be
related to both typesofcancer, then therelationship between the cancers is regarded as
having beenexplained. Nevertheless, a strong casecan be made for a morequantitative
approach to the assessment ofshared risk factors.
Consider the hypothetical numerical example in Table 1. A binary risk factor is
assumed to bepresent in 50 percentofthepopulation. Cancer Aand Cancer B areeach
assumed to develop in 0.1 percent ofpersons who do not have the risk factor and in 0.5
506METHODOLOGY AND MULTIPLE PRIMARY CANCERS
TABLE 1
Example of Calculation of the Odds Ratio for the Association Between Two
Risk Factor in Common
Cancers That Have a
Risk Factor Present
Cancer A
+
Risk FactorAbsent
Cancer A
+
Cancer B
+_
(0.0025)2 (0.0025)(0.4975)
0.5 0.5
(0.4975)(0.0025) (0.04975)2
0.5 0.5
0.0025 0.4975
Cancer B
+_
(0.0005)2 (0.0005)(0.4995)
0.5 0.5
(0.4995)(0.0005) (0.4995)2
0.5 0.5
0.0005 0.4995
Total
Cancer B
+
Cancer B
+_
0.000013 [ 0.002987
0.002987 0.994013
0.003000 0.997000
Odds Ratio = 1.45
percent of those who do have the risk factor, for a relative risk of 5.0. Within the two
categories ofthe risk factor, Cancers A and B are independent, as would be the case if
the shared risk factor were the only basis for the association between the two types of
cancer. Thus, for example, the proportion ofthe population that has the risk factor and
develops Cancer A but not Cancer B is (0.0025)(0.4975)/(0.5) = 0.0024875. At the
bottom ofTable 1 is given the cross-classification for Cancer A and Cancer B without
regard to the shared risk factor. Note that although the risk factor increases the
probability of developing each cancer fivefold, the magnitude of the resulting
association between the cancers is relatively small (odds ratio = 1.45).
Table 2 gives the magnitude of corresponding odds ratios for a variety of
circumstances. The relative risk for the association between the risk factor and each of
the two cancers is varied from 2 to 10, and the prevalence of the risk factor in the
population is varied from 5 percent to 50 percent. Table 2 illustrates that the
magnitude ofthe association between the cancers depends in part on the prevalence of
the shared risk factor and that the association between the cancers is substantial only
when the shared risk factor is strongly related to both ofthe cancers.
These numerical results have some important implications for the study ofmultiple
0.0025
0.4975
0.5000
0.0005
0.4995
0.5000
0.003000
0.997000
1.000000
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TABLE 2
Magnitude of the Odds Ratio for the Association Between Two Cancers
That Have a Risk Factor in Common
Prevalence ofRisk Factor
Relative Risk Relative Risk
for Cancer A for Cancer B 0.05 0.10 0.20 0.50
2 2 1.04 1.07 1.11 1.11
5 1.15 1.23 1.30 1.22
10 1.28 1.39 1.43 1.28
5 5 1.53 1.74 1.80 1.45
10 1.99 2.23 2.15 1.55
10 10 2.85 3.04 2.68 1.68
primary cancers. They clearly indicate that it would be unlikely indeed for a study of
multiple primaries to provide etiologic leads concerning subtle risk factors, the effects
of which had not been detected in other types of epidemiologic studies examining the
risk factors more directly. The results also suggest that a qualitative explanation in
terms of a shared risk factor may not in fact be sufficient to explain the observed
magnitude of association between two cancers. To assess whether additional hypo-
theses should be considered, prior knowledge concerning the magnitude of the
association between the shared risk factor and each ofthe cancers and concerning the
distribution of the risk factor in the population may be used to perform calculations
similar to those in Table 1. The resulting valuegives thestrength ofthe association that
would be anticipated if the shared risk factor were the only basis for a relationship
between the two cancers. Comparison of this value to the observed strength of the
association between the two cancers based on registry data indicates whether
additional explanations for the association between the cancers should be considered.
Correlated Risk Factors
In a recent study of multiple primary cancer in Finland, the authors stress that an
association between twocancers may be induced by two risk factors that are notshared
by the cancers but that tend to be found more frequently in certain subgroups of the
population [24]. For example, they postulate that a negative association between
smoking-related cancers and cancer of the colon is attributable to the relatively high
prevalence ofsmoking and the relatively low prevalenceofrisk factors for cancer ofthe
colon in the lower socioeconomic classes in Finland. Figure 1 illustrates the distinction
between shared risk factors and correlated risk factors.
As a guide to assessing the likely magnitude ofassociation between two cancers as a
result of correlated risk factors, numerical results are presented in Table 3. The
magnitudeofthe relative risk for one risk factor as it relates to Cancer A isvaried from
2 to 10, as is the relative risk for a different risk factor as it relates to Cancer B. The
prevalences for the two risk factors areassumed to beequal in the total population, and
this value is varied from 5 percent to 50 percent. The correlation between the risk
factors in the population is assumed to be fairly substantial throughout. Specifically, it
is assumed that in half of the population (e.g., those below the median on socioeco-
nomic status) the prevalence ofeach ofthe risk factors is four times greater than in the
other halfofthepopulation (e.g., those above the median on socioeconomic status). For
risk factors having a prevalence of 50 percent overall, this degree of correlation
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Shared Risk Factor
Correlated Risk Factors
Risk Factor 1 Risk Factor 2
Cancer A Cancer B
FIG. 1. Shared Versus Correlated Risk Factors in Multiple Primary Cancers Note: Straight arrows
indicate causal relationships, whereas thecurved double-headed arrow indicates a statistical association that
is not causal. For both shared and correlated risk factors, an association is induced between Cancer A and
Cancer B.
between the risk factors corresponds to a prevalence of 80 percent for each of the risk
factors in one halfofthe population and a prevalence of20 percent for each in theother
half.
As would be expected, correlated risk factors related etiologically to different
cancers induce less of an association between the two cancers than does a single risk
factor that is etiologically related to both. The results in Table 3 indicate further that
the association induced by correlated risk factors is generally of extremely small
magnitude. Only when both of the risk factors are strongly related to their respective
cancers is the association large enough to render correlated risk factors a plausible
explanation ofsubstantial observed associations between pairs of cancers. This general
TABLE 3
Magnitude of the Odds Ratio for the Association Between Two Cancers for
Which Risk Factors Are Correlated in the Populationa
Prevalence of Factor 1
Relative Risk Relative Risk and of Factor 2
for Factor 1 for Factor 2
and Cancer A and Cancer B 0.05 0.10 0.20 0.50
2 2 1.00 1.00 1.01 1.04
5 1.00 1.01 1.03 1.08
10 1.01 1.02 1.04 1.10
5 5 1.01 1.03 1.07 1.16
10 1.02 1.05 1.10 1.20
10 10 1.03 1.08 1.15 1.24
'It is assumed that in one halfofthe population the prevalence of Factor 1 and the
prevalence of Factor 2 are each four times as great as in the other half of the
population (e.g., prevalence of0.20 in one halfand 0.80 in the other).
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lack of impact of correlated risk factors on patterns of multiple primary cancers is
probably fortunate from the point of view of inferences concerning etiology. Thus,
when assessing the possible role of risk factors as an explanation for an observed
association between two types of cancer, it is not generally necessary to consider
separate risk factors that may happen to be correlated in the population. The
researcher can concentrate on the more manageable task of attempting to identify a
risk factor that the two cancers might share.
MULTIPLE PRIMARY CANCERS OF THE SAME ORGAN
Provided that the entirety of an organ in which a first primary cancer has arisen is
not removed during the course of therapy, the possibility exists for the occurrence of a
second primary of that same organ. When studying multiple primaries of a single site,
there are two general types of comparisons that can be made. The first type involves
comparisons between those with a first primary cancer of a particular organ and
persons in the general population. These groups are compared in terms of risk for a
subsequent primary cancer of that same organ. The second type involves comparisons
of subgroups of those with a first primary cancer of a particular organ. The subgroups
are compared in terms of the magnitude of risk for subsequent development of a
primary of that same organ.
Comparisons Between Those with a First Primary and the General Population
A number of studies have examined whether, relative to women in the general
population, women who have had a first primary cancer of the breast are at an elevated
risk for the development of a subsequent primary breast cancer [16,28-34]. These
studies have found a substantial elevation in risk, particularly among women whose
first primary breast cancer was diagnosed at an early age. Such information on the
predictive utility of first primary breast cancer as a risk indicator for subsequent
primary breast cancer in the contralateral breast has important clinical implications
concerning appropirate levels of surveillance of various segments of the female
population. Wide excisional biopsy and even prophylactic removal of the contralateral
breast have been considered by some physicians as appropriate for certain women with
a first primary breast cancer [35-37].
When considering multiple primaries of the same organ, the repeated effects of
known risk factors for a first primary cancer are likely to account for at least some of
the observed association between first primary cancer and subsequent risk for the
disease. On average, for example, women with a first primary breast cancer have
higher values on established risk factors for the disease than do women who have not
developed the disease. A question of both clinical and etiologic interest would be
whether a first primary breast cancer has any predictive utility over and above its
serving as an indicator of elevated values on established risk factors for breast cancer.
From a clinical perspective, if it were shown that first primary breast cancer had no
predictive utility beyond what is tapped by established risk factors for breast cancer,
then the clinician should select appropriate levels of surveillance on the basis of a
woman's profile on established risk factors rather than on the basis of whether or not
she has a history of first primary breast cancer. Thus, a woman with a first primary
breast cancer but low values on the established risk factors would have the same risk
for a subsequent breast primary as a woman with a similar risk factor profile but no
first primary breast cancer.
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From an etiologic perspective, an assessment ofwhether first primary breast cancer
has predictive utility beyond established risk factors would possibly shed light on the
nature ofthe currently unexplained portion ofthevariation in risk for breast cancer. If
first primary breast cancer were shown to have no predictive utility after consideration
of established risk factors, then the currently unexplained variation in risk would be
more reasonably attributed to promotional agents to which one's exposure varies
greatly over time than to agents involved in the early stages of carcinogenesis, to
chronic patterns ofexposure, or to stable characteristics ofthe individual.
Special studies to examine directly whether first primary breast cancer has
predictive utility beyond established risk factors would be costly to mount. Prospective
studies ofthis issue require the inclusion oflarge numbers ofwomen with and without a
first primary, collection ofdata on established risk factors, and long-term follow-up for
the incidence of subsequent primary cancers of the breast. In the analysis of such a
study, one would control for the established risk factors to assess whether the group
with a first primary had an independent increment in risk. Case-control studies ofthis
issue would also be rather costly in that a history of prior primary breast cancer is not
an exposure factor of high prevalence, necessitating a fairly large sample size.
Fortunately, indirect methods may also be used to evaluate whether first primary
breast cancer has additional predictive utility over and above the established risk
factors. Available data from case-control studies of first primary breast cancer can be
used for this purpose. These studies involve comparison ofcases having a first primary
cancer to controls from the general population and can be used to obtain logistic
regression equations for the prediction of case-control status [38,39]. To determine
how much higher first primary breast cancer patients are than population controls in
terms of their values on established risk factors for first primary breast cancer, the
mean predicted probability of being in the case group may be calculated for cases and
controls separately, using the logistic regression equation.
For illustrative purposes, this approach has been applied to 889 first primary breast
cancer patients and 878 population controls from a population-based case-control
study conducted in Connecticut. This study was part of a larger collaborative study of
oral contraceptives and breast cancer in women between the ages of 20 and 54 [40]. A
logistic regression equation was fitted to the data, using as predictors the established
risk factors of parity, menopausal status, age at menarche, age at first birth, age at
menopause, obesity, family history of breast cancer, and history of benign breast
biopsy. Information on diet was not collected. Application of the logistic equation to
each member of the case group yielded an average predicted probability of 0.528 for
being a case. The corresponding calculation for controls yielded an average predicted
probability of 0.478. Although these data do not bear directly on the issue of second
primary cancer, they may be used to estimate the magnitude of association between
first and subsequent primary breast cancer that one would anticipate observing if first
primary breast cancer had no predictive utility beyond the established risk factors for
the disease. Comparison of the predicted probabilities for cases and controls from the
Connecticut study yields an odds ratio of [0.528/(l - 0.528)]/[0.478/(1 - 0.478)] =
1.22. That is, if established risk factors for first primary breast cancer have similar
quantitative effects on the incidence ofsecond primary breast cancer, then the elevated
values of these risk factors among women with a first primary breast cancer would
alone be expected to increase their risk of subsequent breast cancer 22 percent above
that of women without a first primary breast cancer. Comparison of this value of 1.22
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to the substantial association between first primary breast cancer and risk of
subsequent breast cancer found in a number ofstudies ofmultiple primaries indicates
that first primary breast cancer has substantial predictive utility over and above the
established risk factors included in the logistic regression equation. Therefore, first
primary breast cancer is an important independent risk factor that clinicians should
continue toconsider in deciding on appropriate levels ofsurveillance. These results also
indicate that the as yet unidentified risk factors for breast cancer are unlikely to be
exclusively promotional factors to which levels of exposure vary widely over time for
given individuals.
Similar applications of logistic regression can be used for evaluations of whether
cancers of different sites are correlated more strongly than would be expected on the
basis of a number of shared risk factors. For example, the same logistic function for
discriminating first primary breast cancer cases from controls may be used to estimate
the expected excess of subsequent breast cancer among women with a first primary
endometrial cancer. Application of the logistic regression equation from the study of
breast cancer to groups of endometrial cancer cases and controls would yield the
magnitude ofassociation between primaries ofthe endometrium and breast that would
be anticipated on the basis only ofshared risk factors included in the equation.
Comparisons AmongSubgroups ofThose Who Have Had a First Primary
The occurrence of a first primary cancer of a particular organ defines a subgroup of
the population of special interest in terms of subsequent primary cancer of that same
organ. For example, among women with a first primary cancer of the breast, only a
minority of those surviving the initial disease develop a second primary cancer in the
contralateral breast [35]. Identification of factors related to risk of second primary
breast cancer among those with a first primary breast cancer would be ofboth clinical
and etiologic interest. Relevant risk factors for study are those known or suspected to
be related to first primary breast cancer and those having to do with the characteristics
of the first cancer itself. This latter group includes histologic type, extent of disease,
hormone receptor status, and mode oftreatment.
Both cohort and case-control studies of these issues have been conducted. For
example, Hankey et al. [32] conducted a cohort study offirst primary breast cancers in
the Connecticut Tumor Registry and compared those treated with surgery plus
radiation to those treated with surgery only in order to assess the possible role of
radiation treatment in the etiology ofsecond primary breast cancer. Hislop et al. [41]
used a case-control approach and compared women developing a second primary
breast cancer to a control group of women who had had a first primary breast cancer
but not a second. Lobular histology for the first primary, absence ofnodal involvement
at time of diagnosis of the first primary, and family history of cancer were found to
differ between cases and controls.
To the extent that certain risk factors may be found in future studies to have
quantitatively or especially qualitatively different effects on second primary breast
cancer than they have on first primary breast cancer, somewhat different disease
processes may be postulated. However, even if second primary breast cancer is not
etiologically distinct from first primary cancer, the study of second primary breast
cancer nevertheless provides a potentially powerful means for detecting the etiologic
role ofcertain risk factors for breast cancer in general. Some such risk factors might be
virtually impossible to study in the context offirst primary breast cancer.
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TABLE 4
Example of the Relationship to First Primary Cancer for a Measured Risk
Factor That Is Modified by an Unmeasured Risk Factor
Unmeasured Risk Factor Present
First Primary Cancer
+ - Risk
Measured + 0.004 0.001 0.005 0.800
Risk Factor 0j001 0.004 0.005 0.200
0.005 0.005 0.010
Unmeasured Risk FactorAbsent
First Primary Cancer
+ - Risk
Measured + 0.010 0.485 0.495 0.020
Risk Factor _ .010 0.485 0.495 0.020
0.020 0.970 0.990
Total
First Primary Cancer
+_
Measured + 0.014 0.486 0.500
Risk Factor - 0.011 0.489 0.500
0.025 0.975 1.000
Odds Ratio = 1.28
Table 4 gives a hypothetical numerical example illustrating one type of situation in
which the study of second primary cancer would be particularly advantageous. In
Table 4, two different risk factors are considered. One risk factor is of low prevalence
(here assumed to be 1 percent), and it either cannot be measured with currently
available techniques or simply has not been considered as a possible etiologic factor.
The other risk factor has been measured and is a strong risk factor for first primary
canceronly among persons who have theunmeasured riskfactor (assumed risksof0.80
versus 0.20 for first primary cancer within the subgroup having the unmeasured risk
factor). Within the large subgroup without the unmeasured risk factor, the risk offirst
primary cancer is 0.02 regardless of whether the measured risk factor is present or
absent. In a study of the incidence of first primary cancer, the observed association
between the measured risk factor and the disease would be as given in the cross-
classification at the bottom of the table. The odds ratio for this association is 1.28,
which would be extremely difficult to detect in either a cohort study or case-control
study.
Table 5 illustrates the advantage of studying the same measured risk factor in the
context of second primary cancer. In this table the study group is composed of those
with a first primary cancer. Note that whereas persons with the unmeasured risk factor
comprise only 1 percent ofthe total in Table 4, such persons comprise 20 percent ofthe
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TABLE 5
Example of the Relationship to Second Primary Cancer for a Measured Risk
Factor That Is Modified by an Unmeasured Risk Factor
Unmeasured Risk Factor Present
Second Primary
Cancer
+ - Risk
Measured + 0.128 0.032 0.160 0.800
Risk Factor [|j0.008 j0.032 0.040 0.200
0.136 0.064 0.200
Unmeasured Risk FactorAbsent
Second Primary
Cancer
+ - Risk
Measured + 0.008 0.032 0.400 0.020
Risk Factor 0.008 0.032 0.400 0.020
0.016 0.784 0.800
Total
Second Primary
Cancer
Measured + 0.136 0.424 0.560
Risk Factor _ jj0.016 | j0.424 0.440
0.152 0.848 1.000
Odds Ratio = 8.50
total in Table 5. In Table 5 it is assumed that the etiologic relationships ofthe two risk
factors to second primary cancer are the same as their relationships to first primary
cancer. Specifically, among those with the unmeasured risk factor there is a risk for
second primary cancer of 0.80 and 0.20 for those with and without the measured risk
factor, and among those without the unmeasured risk factor there is a risk of 0.02,
regardless of whether the measured risk factor is present or absent. The cross-
classification at the bottom ofthe table indicates that the observed association between
the measured risk factor and the disease would be substantial in a study of second
primary cancer (odds ratio = 8.5). Such an association could be detected in even a
small case-control study ofsecond primary cancer.
The example given in Tables 4 and 5 implies that certain measured risk factors that
have not proved important in studies of first primary breast cancer may be masked
because of the low prevalence of an unmeasured risk factor which modifies their
effects. Consequently, although use of oral contraceptives seems not to be related to
risk of breast cancer even in large case-control studies of first primaries [40,42],
studies of second primary breast cancer might change the picture considerably.
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Demonstration of etiologic relationships for second primary breast cancer that have
not been detectable in studies offirst primary breast cancerwould contribute primarily
to an understanding ofthe disease process. Because theenhanced detection ofetiologic
relationships for measured risk factors in studies of second primary breast cancer
depends on potentiation by an unmeasured factor of low prevalence, the proportion of
all breast cancer attributable to such measured risk factors will be small in the
population. However, the new insights into etiology may hold long-term benefit for all
women.
COMMENT
The existence of many long-term cancer registries throughout the world offers rich
opportunities for the study of multiple primary cancers. Close scrutiny of multiple
primary cancers serves the dual purpose ofenlarging our understanding ofcancer and
ensuring the quality of data in the registries. As this methodologic review illustrates,
many aspects of research on multiple primary cancer require additional information
that is not routinely collected by cancer registries. Nevertheless, even for special
studies involving abstraction of medical records and possible interviews of patients,
cancer registries form the cornerstone in terms of the identification of persons for
study.
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